With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the...
In July, the editors from AACR's 10 peer-reviewed journals highlighted research on AI-driven molecular mapping of pancreatic cancer evolution,...
The summer issue of Cancer Today includes articles about integrating patient-reported outcomes into clinical research and care, advances in...
During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO,...
At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President...
Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on...
Exposure to wildfire smoke may increase the risk of developing several cancers, according to research presented at the AACR...
Cancer researchers—including Elizabeth M. Jaffee, MD, FAACR, of the Sidney Kimmel Cancer Center at Johns Hopkins; Robert H....
After surviving brain cancer, former competitive cyclist Chris Baccash dedicated his life to helping others. Baccash now uses his...
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed how...
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...